How We’re Mobilizing Our Resources to Help Find Solutions for COVID-19
Learn More
Share
Access to the Medicines, Products, Devices and Solutions You Depend On
Taking measures to ensure patients and providers have access to the medicines, products, devices and solutions they depend on
Our team at Johnson & Johnson has robust business continuity plans in place across its global supply chain network to prepare for unforeseen events like the coronavirus outbreak. These steps include maintaining critical inventory at major distribution centers away from high-risk areas and working with external suppliers to support our preparedness plans.
We are closely monitoring product demand and supply levels across our global network to ensure adequate and effective distribution and are working diligently to meet patient, customer and consumer needs. Learn more here.
Learn More About Our Efforts
More From Johnson & Johnson
July 30, 2020
A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.
June 03, 2020
Think you are up to speed on the novel coronavirus? Take this quiz to test your virus knowledge.
July 20, 2020
The U.S. has one of the highest maternal mortality rates in the developed world, with women of color especially at risk. Dr. Robyn R. Jones, Senior Medical Director at Johnson & Johnson, is determined to change that and find ways to address this urgent crisis.
